Clinical trial Recruiting at 1 site Observational Ages 22 and up

Neuspera SNM System follow-up: comparing patient experience with traditional SNM

Official title: Follow-up Revision Experience and Evaluation of Device Outcomes Metrics in Subjects Receiving Replacement of Traditional Sacral Neuromodulation (SNM) With the Neuspera SNM System

Run by Neuspera Medical, Inc. · NCT07383688 · Data updated 2026-11-12

We’re testing whether patients who switch from a traditional sacral neuromodulation device to the Neuspera SNM System report similar or better experiences after about one month.

Quick facts

Study typeObservational
Ages22 Years and up
SexAll
Enrollment100 (estimated)
SponsorNeuspera Medical, Inc.
Industry-sponsored
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedApril 1, 2026
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedOctober 14, 2026
Trial IDNCT07383688 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 22 years or older who have or recently had a traditional SNM device and meet response criteria in prior bladder diaries.

Probably not a fit

Patients who do not experience perceived improvement or who have contraindications to Neuspera may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, single-arm study will enroll up to 20 adults with urinary urge incontinence who currently have or recently removed a traditional SNM device and are receiving the Neuspera implant. Participants complete a pre-implant questionnaire about their experience with the traditional SNM and then undergo implantation of the Neuspera device followed by a 1-month follow-up. The study uses standard-of-care implantation and aims to compare patient-reported outcomes after switching devices. Data will describe perceived changes in comfort, effectiveness, and overall satisfaction related to the Neuspera system.

Why it matters

Potential benefit: If successful, patients may experience improved satisfaction and perceived effectiveness after switching to Neuspera SNM.

How similar studies have gone: Previous SNM device changes have shown variable but informative patient-reported outcomes; this study adds a focused comparison for Neuspera in a real-world setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Currently have a traditional SNM device and has decided to have the device replaced with the Neuspera SNM System OR previously had an existing traditional SNM implant that was completely removed within the last year
2. Is 22 years of age or older
3. Had documented at least 50% improvement in UUI episodes on a bladder diary with either a stimulation trial or with their traditional system
4. Is a good surgical candidate and qualified to receive the Neuspera SNM System per the device labeling
5. Is capable of participating in all testing and follow-up clinic visits associated with this clinical study.

Exclusion Criteria:

1. Has a contraindication for the Neuspera SNM System per the device labeling.
2. Has plans to enroll or is currently enrolled in another investigational device or drug trial during his/her participation in this study

Where it's running

  • Specialty Clinical Research of St. Louis
    St Louis, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.